{"cmr":"fr-cm-kg/XPAR/FR0000074197","since":null,"total":41,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-11-05","event_type":"results","title":"Intensity Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/intensity-therapeutics-reports-third-quarter-2026-financial-results-and-provides-business-update-302930462.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"yERdyRM9XqB83w0N9OQqAh87gbgparw9-tavBRyVGX840hCVUSN8qZK01O6sKBcL5JKYF8bsIsBb0EDqN4M_AQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-11-05","event_type":"results","title":"Enliven Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Business Update","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/enliven-therapeutics-reports-third-quarter-2026-financial-results-and-provides-a-business-update-302931099.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"yDAQMXeBp4XZiRtABc7_aKra5xdaQiHVqCr27ldGmfc6nUhwO4vFgrqmBoi34nWCsgfVwb6cLcr0J83aibdqBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-11-04","event_type":"results","title":"Edgewise Therapeutics Reports Third Quarter 2026 Financial Results","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/edgewise-therapeutics-reports-third-quarter-2026-financial-results-302929509.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"rviJc6ZJP1v9KyCcHqIv-fCuZAa5u31bj5OIZOJfGFLglvC8rL1pUdaJ6h_1VPWVeUXeKDl_1qt8rxH6yhIFAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-11-03","event_type":"newswire_release","title":"Viking Therapeutics to Participate at Upcoming Investor Conferences","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/viking-therapeutics-to-participate-at-upcoming-investor-conferences-302928444.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"mlskOZv-CWU_L24yrfDKRU-yYU5JGlmjQbWs8P9no09CIeOXucom_fCscbWJQNLd5Xm0xluet4SdmJjHNKOgDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-11-03","event_type":"newswire_release","title":"Thryv Therapeutics Announces $30 Million Financing to Launch the ASPIRE-HF Study in Patients with Heart Failure; Wave II Efficacy Cohort Fully Enrolled in Long QT Syndrome","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/thryv-therapeutics-announces-30-million-financing-to-launch-the-aspire-hf-study-in-patients-with-heart-failure-wave-ii-efficacy-cohort-fully-enrolled-in-long-qt-syndrome-302926937.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"IZD1hnamVRG29Nxx3IkHhNPOIVRqS3kv7vp0aEHDD7LsiVDNChB3oTJYPNUspTtoIw_glXOsslcuz1E5HU1zCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-11-02","event_type":"newswire_release","title":"Karyopharm Therapeutics Inc. Announces Planned Merger with Ayrmid Ltd. to Strengthen Company for the Future","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/karyopharm-therapeutics-inc-announces-planned-merger-with-ayrmid-ltd-to-strengthen-company-for-the-future-302926356.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"SMSY2QorZWYxrz2G9HVU_MvrHRy6-KF9WhZd7gE7Wa0Ozwo-Aot1tr-QkVG-nNNBBRiW7KEVZxyQeSjq6lmnAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-11-02","event_type":"newswire_release","title":"ADC Therapeutics Announces New Employee Inducement Grant","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/adc-therapeutics-announces-new-employee-inducement-grant-302925153.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ebbPc3HUHX6UcU_WBf64_PQ-ENnDE3Uk0XyJ74ti7niZ5cqTCQ1_5rv25Ewfq5xqUo8XtXA79ohu4EcUB6UzAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-10-28","event_type":"newswire_release","title":"TENX Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Tenax Therapeutics, Inc. - PR Newswire","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/tenx-stockholder-notice-shareholder-rights-law-firm-robbins-llp-reminds-investors-of-the-class-action-lawsuit-against-tenax-therapeutics-inc-302921469.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"JcgbKgw98Kh2IP0mzKP6i7pA6gsAHOtJmpvEsOi1pRji86ymIGEGQuuBHC0J5aMJJhqgDHBnC55Y4qKQMhisCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-10-28","event_type":"results","title":"Viking Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/viking-therapeutics-reports-third-quarter-2026-financial-results-and-provides-corporate-update-302922632.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"P011byJ60rojPcNkqUKYwSf3sAPk15AkUu8lFaEFPsrWILpGLS1ssnYvpfu7xlM8mqHYfIL-7JJahZggJA9ZDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-10-27","event_type":"newswire_release","title":"Monolithic Power Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Monolithic Power Systems, Inc. – MPWR - Business Wire","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20261026235789/en/Monolithic-Power-Investor-News-Rosen-Law-Firm-Announces-Investigation-of-Breaches-of-Fiduciary-Duties-by-the-Directors-and-Officers-of-Monolithic-Power-Systems-Inc.-MPWR","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"nBDYO7YOVt2OtMKjFQHEe5e1zdp7Kp2Oc5ZkROduzgEQG0as3GR__p-22fiq3bYCZlt_vQ8Ni6QR2dtSyUymBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-10-27","event_type":"newswire_release","title":"Vensure Employer Solutions Launches AI Orchestrator to Help SMBs Manage the Digital Workforce - PR Newswire","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/vensure-employer-solutions-launches-ai-orchestrator-to-help-smbs-manage-the-digital-workforce-302919850.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"s9OjLIk0s-9zJcBNu8FeOMVm0edlHRk911ij1Z9ZpGzaXSaqPxuWIwAxbHR2vFzJkUfEgJfMKzddSJuLB7JwDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-10-27","event_type":"newswire_release","title":"KellyOCG® Ranks No. 1 on HRO Today’s 2026 Total Workforce Solutions Baker’s Dozen - GlobeNewswire","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/27/3389078/0/en/kellyocg-ranks-no-1-on-hro-today-s-2026-total-workforce-solutions-baker-s-dozen.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"6TE_5C9VqjLgyLi3Lca2D65O8r4_wo7OB4valz7INlaSKCXH-FYStwDFeA2eZpNGD9Nb5BR0b_uMTbtMXHnlDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-10-26","event_type":"newswire_release","title":"TransCode Therapeutics Presents Phase 1a Clinical Data for TTX-MC138 at ESMO Congress 2026","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/transcode-therapeutics-presents-phase-1a-clinical-data-for-ttx-mc138-at-esmo-congress-2026-302918795.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"8Ypoa1AM8jFYiB47XrY23ZweYLvaWQu4joAW1nyRA3meErLmY8S3JxMeasXk6T_x_ZDt7ultCRn7xxLQDsibBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-10-26","event_type":"newswire_release","title":"Merz Therapeutics Presents New Phase 2 PaiNT Data in ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20261023526805/en/Merz-Therapeutics-Presents-New-Phase-2-PaiNT-Data-in-Peripheral-Neuropathic-Pain-at-IASP-2026","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"P6j0kOpGWV1B2hJ3zvgJMT5I3q7Ji5IFer_L3TkYlmbNCFletARes3H5LzSP-mrPRbuTzg6Kx8g1GsL1mKWGBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-10-23","event_type":"newswire_release","title":"Congruence Therapeutics Announces Oral Presentation on CGX-195, a Novel Small Molecule AAT Corrector, at the ERS Alpha-1 Antitrypsin (AAT) Conference 2026","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/congruence-therapeutics-announces-oral-presentation-on-cgx-195-a-novel-small-molecule-aat-corrector-at-the-ers-alpha-1-antitrypsin-aat-conference-2026-302918161.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"7mI-5rP5AcQNxVk2BTtEJKQ5lCFyaQQbbe0uaBRnorEZaDa2DmtoUF7xGkWgZ0F_7IWOvUtnb5I_Hp5cmHdmCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-10-23","event_type":"newswire_release","title":"Marengo Therapeutics Presents Phase 2 STARt-001 Results at ESMO 2026 Demonstrating Tissue-Agnostic Single-Agent Activity of Invikafusp Alfa in TMB-H Solid Tumors Mostly Unresponsive to Immune Checkpoint Blockade","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/marengo-therapeutics-presents-phase-2-start-001-results-at-esmo-2026-demonstrating-tissue-agnostic-single-agent-activity-of-invikafusp-alfa-in-tmb-h-solid-tumors-mostly-unresponsive-to-immune-checkpoint-blockade-302917324.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"09hB-3ejNjnz_hfbDOYvj6uq26P08U6j2KQzGQCeDECUsToNecappDQXR3Rm5ZTzLNUviC7xwtP0z7sm6Qt7Cg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-10-23","event_type":"newswire_release","title":"Intensity Therapeutics, Inc. to Present INVINCIBLE-4 Neoadjuvant Triple-Negative Breast Cancer Study Data for the First Seven (7) Patients After INT230-6 Treatment (Cohort A) in an ePoster Presentation at the European Society of Medical Oncology (ESMO) Meeting","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/intensity-therapeutics-inc-to-present-invincible-4-neoadjuvant-triple-negative-breast-cancer-study-data-for-the-first-seven-7-patients-after-int230-6-treatment-cohort-a-in-an-eposter-presentation-at-the-european-society-of-m-302917587.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ZxWVtPz6ZBsb0HpulROwPdRXQ9fkCK3cu-3JzvgD8C1B-7C6ZlCFqkjA5omiOy2e8qGOHnr9Axwt1kdxmCpeAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-10-23","event_type":"newswire_release","title":"Congruence Therapeutics Announces Oral Presentation on CGX-195, a Novel Small Molecule AAT Corrector, at the ERS Alpha-1 Antitrypsin (AAT) Conference 2026","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/congruence-therapeutics-announces-oral-presentation-on-cgx-195-a-novel-small-molecule-aat-corrector-at-the-ers-alpha-1-antitrypsin-aat-conference-2026-302918168.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"xPaYnnL9GUW3cR_1PyUvZxuyI7MYno86h-0IfbOZy8Zu_EglMt81qUHTJMhUE3S1FFj3OOrN5FAsNDjTPjG8Ag","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-10-09","event_type":"newswire_release","title":"Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Sprout Social, Inc. - SPT - PR Newswire","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/rosen-law-firm-announces-investigation-of-breaches-of-fiduciary-duties-by-the-directors-and-officers-of-sprout-social-inc--spt-302903898.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"W-U3QMRsXGQZoXTLLzz3QRp1a__LLER9FyMALc25m8I_w6BwnbNsT7qrnbn7tN97Sl0FrVXqPSjXlA7jxLF6Ag","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-10-08","event_type":"newswire_release","title":"myKaarma Offers New AI Lead Management Solutions to Ford and Lincoln Dealerships","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/mykaarma-offers-new-ai-lead-management-solutions-to-ford-and-lincoln-dealerships-302901724.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"VQ8esu2kdtbQjyMeH3nKE_ZvD3PRZL90Uv1sDzUkyheLyS6um4xlUUAvWdeRQkGuLZVeEahmPPXmZNaoOkm2CQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-10-08","event_type":"newswire_release","title":"ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/adc-therapeutics-announces-comprehensive-strategic-financial-restructuring-marking-key-capital-structure-improvements-302902376.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"x6gl_exOWv8b6AApUmlcgOYNy1ai8aIa4nqOpr5WZ7rNDQkphlKNJVs1ip6v2HK8_zEV9DoPZhf4hB24oXVSDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-10-08","event_type":"newswire_release","title":"Saol Therapeutics Announces Completion of Enrollment in Pivotal Phase III BEACON Trial of SL1002 for the Treatment of Chronic Pain Related to Osteoarthritis of the Knee","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/saol-therapeutics-announces-completion-of-enrollment-in-pivotal-phase-iii-beacon-trial-of-sl1002-for-the-treatment-of-chronic-pain-related-to-osteoarthritis-of-the-knee-302901305.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"dwuf5p6STHES8f1ZXQZUUKkir6-JB02VJQD-HbJ6edTFbn04Qw_Lw7uCdotBeLWZ2YyrEi4kUCKmn0PdfCNAAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-10-07","event_type":"newswire_release","title":"Lakewood-Amedex Biotherapeutics Announces Positive Preclinical Data in Urinary Tract and Pulmonary Infection Indications with Bisphosphocin® Compounds","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/lakewood-amedex-biotherapeutics-announces-positive-preclinical-data-in-urinary-tract-and-pulmonary-infection-indications-with-bisphosphocin-compounds-302900567.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"aS3HUNOCvqBC9M2t_Jqa4_9hHVq8YRI_nkkluZLUSdCOYuxNQWuBaRC4SPpz3ZgMFoVGLKvgyRd99LFXxk7eBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-10-07","event_type":"newswire_release","title":"Bambusa Therapeutics Appoints Jonathan I. Lieber as Chief Financial Officer","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/bambusa-therapeutics-appoints-jonathan-i-lieber-as-chief-financial-officer-302900489.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"gsoSManL_74rBIfHnbdRwCmED5S8FMwexhViOzD6fZkvIFB5KUXRs5RN0-l_hj_wMhrvCiQqgrrLes-UP8zWAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-10-07","event_type":"newswire_release","title":"Halia Therapeuticsto Participate in the 6th Annual Needham Private Biotech & MedTech Company Virtual 1x1 Forum","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/halia-therapeuticsto-participate-in-the-6th-annual-needham-private-biotech--medtech-company-virtual-1x1-forum-302900689.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"cbfWRdc7gfSuWMuaIZcWIc63fcbfS5HrxXZEzF3CvWOfNcxvmjKZxlGgx3YQP9cmJFL4Hzn08U8J3cIriWgKBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-10-06","event_type":"newswire_release","title":"Enliven Therapeutics Announces FDA Alignment on ENABLE-2 Phase 3 Trial Design for Relcobatinib (ELVN-001) in Previously Treated Chronic Myeloid Leukemia","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/enliven-therapeutics-announces-fda-alignment-on-enable-2-phase-3-trial-design-for-relcobatinib-elvn-001-in-previously-treated-chronic-myeloid-leukemia-302900300.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Np0EPqBoDqKyD7U-NtIR_jtl97UWm29lMdcBSqsVA-R3yiWSAbeCb6ZzFY0k8iWlY1LlFNi3RQypv0Chi2YcAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-10-01","event_type":"newswire_release","title":"Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/karyopharm-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635c4-302894983.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"wNnEi6TX2XJaNaw5zh_5dBXrqtOZatIHUO2tNE0qO8h5I8r7Xu7FRRMV0N9TklbZk7-Hj3RQl4QVeBiO4Fl4Dg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-10-01","event_type":"newswire_release","title":"Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/edgewise-therapeutics-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-302895364.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"8QiavnjuKqeHg2y3O8RbVC8F77nqkeVUT-dR46_yLIqjbNISxkkbiNSe5i50F3_1jst99dfqPQdu2cx-eTX3Aw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-10-01","event_type":"newswire_release","title":"Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/whitehawk-therapeutics-presents-real-world-analyses-supporting-muc16-as-a-durable-adc-target-in-ovarian-cancer-at-igcs-2026-302895391.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ULzkEMs3y9uYK47huOX3_-NdosnLk4l7zjeifvTFuLo1lx1XpYwuhmRzwFylF9FtP-fLzdo85lSnd53OFKMrBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-09-29","event_type":"newswire_release","title":"myKaarma and Universal Technical Institute Announce Pilot Program at UTI-Atlanta","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/mykaarma-and-universal-technical-institute-announce-pilot-program-at-uti-atlanta-302892350.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"km-2zDINr3RbCMoOMK2xu2T2jF4eWHnc7pFmIty415x-TRizmCrO8eN0pzujSWbvlnCPi9ok1K0QCUdHZrSUBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-09-29","event_type":"results","title":"UTI GROUP : CHIFFRE D'AFFAIRES ET RESULTATS DU ...","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/09/30/3371521/0/fr/uti-group-chiffre-d-affaires-et-resultats-du-premier-semestre-2026.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"oIrjo0H4rmczbE8HPCqJD79m2vooB-wXy3pfwvRFnw4S9hcVLk17NAH4IU16p5hZGq619BXRw1PdLxOe0kHuDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-09-28","event_type":"newswire_release","title":"Viking Therapeutics Announces Closing of Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes, Including Full Exercise of Underwriters' Options to Purchase Additional Shares of Common Stock and Convertible Senior Notes","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/viking-therapeutics-announces-closing-of-concurrent-upsized-offerings-of-common-stock-and-convertible-senior-notes-including-full-exercise-of-underwriters-options-to-purchase-additional-shares-of-common-stock-and-convertible-sen-302891919.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"OeSbgRrgDgqAby3gQ_zBq4mTW1IxYagRZ8tuxWRyRWWPqpGFk5nrqETvEQ-EKt3-IuVlb9Xagh7JHUxouSgtCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-09-10","event_type":"newswire_release","title":"TransCode Therapeutics Announces Leadership Transition","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/transcode-therapeutics-announces-leadership-transition-302875754.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"9kgHtK9iXum81T6HrH2ml7FlEXV3x_N6VFCH3uT9VFeKxihSsSjCc4sioD5OYMxw0KMSeHlK7Qcc-ABiGdyFDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-09-10","event_type":"newswire_release","title":"Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/whitehawk-therapeutics-appoints-vijay-iyengar-md-to-board-of-directors-302875492.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"0nmmjSxh6TzDXFUydHi0AEQcl2N41CBltP0p8UdON5BjvpzGRkhlI4O1gx53hEYlAgdWET8PHgXZ_pKeT8zMAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-09-09","event_type":"newswire_release","title":"Halia Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/halia-therapeutics-to-present-at-the-morgan-stanley-24th-annual-global-healthcare-conference-302873282.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"V_oHla9tZWJCkO6e-Q6M2u9g6vG0gBywiAy-yUZofW5Rty-5R30GaIWeJ04GxGkG157IilHs6Bw7W78cH1U-DA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-09-09","event_type":"newswire_release","title":"Ratio Therapeutics Enters into Research Collaboration and License Agreement with RayzeBio to Advance a Novel Radiopharmaceutical Program","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/ratio-therapeutics-enters-into-research-collaboration-and-license-agreement-with-rayzebio-to-advance-a-novel-radiopharmaceutical-program-302872946.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"eoKr1DggG1Amt9rJCty1yZ7ZWxz3ofJI9VhXW9wSlr0wjqXp0tkBviu9WnflqIY8cDmL9iFKrTJgYc5SU_S1Cw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-09-09","event_type":"newswire_release","title":"Marengo Therapeutics Completes Enrollment in Phase 1/2 STARt ...","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/marengo-therapeutics-completes-enrollment-in-phase-12-start-001-monotherapy-cohorts-and-strengthens-leadership-to-advance-invikafusp-alfa-toward-late-stage-development-302872814.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"FvvzndLzaNE4_yZanwrvJhcea4JSctEu0dipyMI7VGYoq1FLxAid46jeQN5A55D3HWLgfEqLjjjVhlvhCPwmBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-09-08","event_type":"newswire_release","title":"Intensity Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/intensity-therapeutics-to-participate-in-the-hc-wainwright-28th-annual-global-investment-conference-302868720.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"yGhIUhVaVTNsCvHCrbl__mES5ppqPwcNUTXgQJG06j2jY8ogDEvZYq70T-BuPvdZrFX-ZzU1S4zoGfwTCwqXAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-09-02","event_type":"newswire_release","title":"Vertiv Announces Agreement to Acquire UtilityInnovation Group to Accelerate Time to Power for AI Data Centers - PR Newswire","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/vertiv-announces-agreement-to-acquire-utilityinnovation-group-to-accelerate-time-to-power-for-ai-data-centers-302867612.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"PjTDKjhIk8nhwoakbRY9w5iTG2Mzj_Ey8ff-SugEX6VUhvEtAG2PaGXjo1PiPJwYusaLmwsjRxS_CHv5mA5_DQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2026-01-12","event_type":"newswire_release","title":"Cytovale's IntelliSep® Named Modern Healthcare's Best in Business for Second Consecutive Year - PR Newswire","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/cytovales-intellisep-named-modern-healthcares-best-in-business-for-second-consecutive-year-302658367.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"SmdmOmUFbSxiLuMEZomGjDYcGOqoVi7CeIzzQjwtfzZ4yqVeJYANpXdj4Y0tQR_jJPMt0ScthppimINkHaa5BA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0000074197","date":"2025-10-27","event_type":"newswire_release","title":"YY Group Outlines 2025 Growth Strategy Featuring Global Workforce Solutions and IFM Expansion - PR Newswire","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/yy-group-outlines-2025-growth-strategy-featuring-global-workforce-solutions-and-ifm-expansion-302595198.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"TudSmd3MuOAJwCBJr98ZxCNPyIPnbgLUppRF-jXRkz-f5mmFKxQZyvFBOVYkTIGZwvESnPCvlBHHtkdy8O3hAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}